The EAP Prescription Drug Toolkit and Fact Sheets provide guidance related to counseling, referrals, and follow-up services (e.g., alternatives to prescription drugs, workplace drug misuse and relapse prevention, dangers of combined drug use, screenings, and evaluations before returning to work).
Dashboard: Filter Bricks
Main page content
This quick guide contains an overview of the challenges associated with tobacco cessation and the benefits of being tobacco-free for individuals as well as those of a smoke-free workplace. It also includes tips that substance use disorder treatment settings can use to implement their own tobacco cessation programs.
Designed for organizations that provide services to older adults, this toolkit offers information and materials to help understanding the issues associated with substance misuse and mental illness in older adults. The toolkit also contains materials to educate older adults.
This resource provides information for clinicians who may encounter patients living with cognitive deficits related to chronic substance use disorder.
This comprehensive kit provides substance use disorder treatment professionals with a year-long intensive outpatient treatment model. Professionals can use this model when treating clients who are dependent on stimulant drugs, such as methamphetamine and cocaine.
The referenced PowerPoint Presentation Sessions are available for download.
View recommendations for related products.
This guide educates substance use counselors and clinicians about detoxification and withdrawal. It addresses patient placement, detox services for specific substances, co-occurring disorders, financing issues, and screening and assessment tools.
This guide contains patient materials for an intensive outpatient treatment course for stimulant misuse. It provides handouts to use in individual and conjoint sessions, and sessions on early recovery skills and relapse prevention.
This chart book reports estimates of mental health service use among adults in the United States within different racial and ethnic groups. Highlights include past year use of mental health service, use of prescription psychiatric medication, and use of outpatient and inpatient mental health service.
This report presents spending information for treatment of mental illness, substance use disorders, or both for people only enrolled in Medicaid, and those enrolled in both Medicaid and Medicare. The report also covers fee-for-service spending and managed care spending.
This guide introduces professional care providers to borderline personality disorder (BPD). It covers signs and symptoms of BPD, with or without co-occurring substance use disorder. The guide also discusses the importance of monitoring clients for self-harm and suicide, and referrals to treatment.
Displaying 1 - 10 out of 22